Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Strategies for mitigating an influenza pandemic

Abstract

Development of strategies for mitigating the severity of a new influenza pandemic is now a top global public health priority. Influenza prevention and containment strategies can be considered under the broad categories of antiviral, vaccine and non-pharmaceutical (case isolation, household quarantine, school or workplace closure, restrictions on travel) measures1. Mathematical models are powerful tools for exploring this complex landscape of intervention strategies and quantifying the potential costs and benefits of different options2,3,4,5. Here we use a large-scale epidemic simulation6 to examine intervention options should initial containment6,7 of a novel influenza outbreak fail, using Great Britain and the United States as examples. We find that border restrictions and/or internal travel restrictions are unlikely to delay spread by more than 2–3 weeks unless more than 99% effective. School closure during the peak of a pandemic can reduce peak attack rates by up to 40%, but has little impact on overall attack rates, whereas case isolation or household quarantine could have a significant impact, if feasible. Treatment of clinical cases can reduce transmission, but only if antivirals are given within a day of symptoms starting. Given enough drugs for 50% of the population, household-based prophylaxis coupled with reactive school closure could reduce clinical attack rates by 40–50%. More widespread prophylaxis would be even more logistically challenging but might reduce attack rates by over 75%. Vaccine stockpiled in advance of a pandemic could significantly reduce attack rates even if of low efficacy. Estimates of policy effectiveness will change if the characteristics of a future pandemic strain differ substantially from those seen in past pandemics.

Access to this article via ICE Institution of Civil Engineers is not available.

This is a preview of subscription content, access via your institution

Access options

Access to this article via ICE Institution of Civil Engineers is not available.

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Baseline pandemic dynamics.
Figure 2: Impact of travel restrictions and case-targeted policies.
Figure 3: Impact of household/socially targeted policies.
Figure 4: Impact of vaccination and combination strategies.

Similar content being viewed by others

References

  1. World Health Organisation. WHO global influenza preparedness plan. http://www.who.int/csr/resources/publications/influenza/GIP_2005_5Eweb.pdf (2005).

  2. Ferguson, N. M., Donnelly, C. A. & Anderson, R. M. Transmission intensity and impact of control policies on the foot and mouth epidemic in Great Britain. Nature 413, 542–548 (2001)

    Article  ADS  CAS  PubMed  Google Scholar 

  3. Keeling, M. J. et al. Dynamics of the 2001 UK foot and mouth epidemic: stochastic dispersal in a heterogeneous landscape. Science 294, 813–817 (2001)

    Article  ADS  CAS  PubMed  Google Scholar 

  4. Riley, S. et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science 300, 1961–1966 (2003)

    Article  ADS  CAS  PubMed  Google Scholar 

  5. Lipsitch, M. et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 300, 1966–1970 (2003)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ferguson, N. M. et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437, 209–214 (2005)

    Article  ADS  CAS  PubMed  Google Scholar 

  7. Longini, I. M. Jr et al. Containing pandemic influenza at the source. Science 309, 1083–1087 (2005)

    Article  ADS  CAS  PubMed  Google Scholar 

  8. Oakridge National Laboratory. Landscan global population data. http://www.ornl.gov/sci/gist/landscan (2003).

  9. Anderson, R. M. & May, R. M. Infectious Diseases of Humans; Dynamics and Control (Oxford Univ. Press, Oxford, 1991)

    Google Scholar 

  10. Chotpitayasunondh, T. et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg. Infect. Dis. 11, 201–209 (2005)

    Article  PubMed  PubMed Central  Google Scholar 

  11. The Writing Committee of the WHO Consultation on Human Influenza A/H5N1. Current concepts—Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353, 1374–1385 (2005)

    Article  Google Scholar 

  12. World Health Organisation Writing Group. Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg. Infect. Dis. 12, 88–94 (2006)

    Article  Google Scholar 

  13. Lo, J. Y. et al. Respiratory infections during SARS outbreak, Hong Kong, 2003. Emerg. Infect. Dis. 11, 1738–1741 (2005)

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bell, D. M. Public health interventions and SARS spread, 2003. Emerg. Infect. Dis. 10, 1900–1906 (2004)

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hufnagel, L., Brockmann, D. & Geisel, T. Forecast and control of epidemics in a globalized world. Proc. Natl Acad. Sci. USA 101, 15124–15129 (2004)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  16. World Health Organisation Writing Group, Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg. Infect. Dis. 12, 81–87 (2006)

    Article  Google Scholar 

  17. Hong Kong International Airport. http://www.hongkongairport.com/eng/aboutus/statistics.html (2003).

  18. Gani, R. et al. Potential impact of antiviral drug use during influenza pandemic. Emerg. Infect. Dis. 11, 1355–1362 (2005)

    Article  PubMed  PubMed Central  Google Scholar 

  19. Coombes, R. UK stocks up on antiviral drug to tackle flu outbreak. Br. Med. J. 330, 495 (2005)

    Google Scholar 

  20. Ferguson, N. M., Mallett, S., Jackson, H., Roberts, N. & Ward, P. A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals. J. Antimicrob. Chemother. 51, 977–990 (2003)

    Article  CAS  PubMed  Google Scholar 

  21. Longini, I. M. J., Koopman, J. S., Monto, A. S. & Fox, J. P. Estimating household and community transmission parameters for influenza. Am. J. Epidemiol. 115, 736–751 (1982)

    Article  PubMed  Google Scholar 

  22. Cauchemez, S., Carrat, F., Viboud, C., Valleron, A. J. & Boelle, P. Y. A. Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat. Med. 23, 3469–3487 (2004)

    Article  CAS  PubMed  Google Scholar 

  23. Ferguson, N. M. et al. Planning for smallpox outbreaks. Nature 425, 681–685 (2003)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ferguson, N. M., Fraser, C., Donnelly, C. A., Ghani, A. C. & Anderson, R. M. Public health risk from the avian H5N1 influenza epidemic. Science 304, 968–969 (2004)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the National Institute of General Medical Sciences MIDAS Program (N.M.F., D.A.T.C. and D.S.B.), the Medical Research Council (N.M.F.), the Royal Society (N.M.F. and C.F.) and the Howard Hughes Medical Institute (N.M.F.) for research funding. We thank B. Schwartz, R. Robinson, B. Gellin, D. Harper, J. Edmunds, P. Grove, R. Hatchett and members of the MIDAS consortium for useful discussions. We also thank the National Center for Supercomputing Applications (NCSA) and the MIDAS informatics group for computational resources and technical advice. Author Contributions N.M.F. designed, implemented and ran the model, integrated the demographic and disease data sets used, and drafted and revised the text. All other authors edited or commented on the text. D.C. identified, collated and processed some demographic and travel data sets used and provided input on model assumptions. C.F. performed analytical modelling that aided the verification of the simulation and gave suggestions on model parameterization. J.C.C. assisted with the collation of demographic and travel data sets. P.C.C. assisted with provision of high performance computing facilities and technical advice. D.S.B. provided input into model design and assumptions, advised on the presentation of results and assisted with data collection.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neil M. Ferguson.

Ethics declarations

Competing interests

Reprints and permissions information is available at npg.nature.com/reprintsandpermissions. The authors declare no competing financial interests.

Supplementary information

Supplementary Notes

This file contains information on datasets and modelling methods used, model parameterization and sensitivity analyses. (PDF 847 kb)

Supplementary Video 1

This file shows the first 140 days of a pandemic in Great Britain, assuming a moderate level of transmissibility (R0=1.7). The movie starts on day 40 of the global pandemic, just before the first cases entering the country. The video runs at the rate of three days model time per second of video time. Grey scale represents population density of uninfected, susceptible individuals. Red represents density of infected individuals, and green represents areas where the epidemic is over. 58.1 million individuals were modelled in the GB simulation. (AVI 24623 kb)

Supplementary Video 2

This file shows the first 170 days of a pandemic in the United States of America, assuming a moderate level of transmissibility (R0=1.7). The movie starts on day 40 of the global pandemic, just prior to the first cases entering the country. The video runs at the rate of three days model time per second of video time. Grey scale represents population density of uninfected, susceptible individuals. Red represents density of infected individuals, and green represents areas where the epidemic is over. 300 million individuals were modelled in the US simulation. (AVI 27934 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferguson, N., Cummings, D., Fraser, C. et al. Strategies for mitigating an influenza pandemic. Nature 442, 448–452 (2006). https://doi.org/10.1038/nature04795

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature04795

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing